- Conti, Heather R;
- Bruno, Vincent M;
- Childs, Erin E;
- Daugherty, Sean;
- Hunter, Joseph P;
- Mengesha, Bemnet G;
- Saevig, Danielle L;
- Hendricks, Matthew R;
- Coleman, Bianca M;
- Brane, Lucas;
- Solis, Norma;
- Cruz, J Agustin;
- Verma, Akash H;
- Garg, Abhishek V;
- Hise, Amy G;
- Richardson, Jonathan P;
- Naglik, Julian R;
- Filler, Scott G;
- Kolls, Jay K;
- Sinha, Satrajit;
- Gaffen, Sarah L
Signaling through the IL-17 receptor (IL-17R) is required to prevent oropharyngeal candidiasis (OPC) in mice and humans. However, the IL-17-responsive cell type(s) that mediate protection are unknown. Using radiation chimeras, we were able to rule out a requirement for IL-17RA in the hematopoietic compartment. We saw remarkable concordance of IL-17-controlled gene expression in C. albicans-infected human oral epithelial cells (OECs) and in tongue tissue from mice with OPC. To interrogate the role of the IL-17R in OECs, we generated mice with conditional deletion of IL-17RA in superficial oral and esophageal epithelial cells (Il17raΔK13). Following oral Candida infection, Il17raΔK13 mice exhibited fungal loads and weight loss indistinguishable from Il17ra-/- mice. Susceptibility in Il17raΔK13 mice correlated with expression of the antimicrobial peptide β-defensin 3 (BD3, Defb3). Consistently, Defb3-/- mice were susceptible to OPC. Thus, OECs dominantly control IL-17R-dependent responses to OPC through regulation of BD3 expression.